Correlation Between Collegium Pharmaceutical and Evotec SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Evotec SE, you can compare the effects of market volatilities on Collegium Pharmaceutical and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Evotec SE.

Diversification Opportunities for Collegium Pharmaceutical and Evotec SE

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Collegium and Evotec is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Evotec SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Evotec SE go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Evotec SE

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 0.71 times more return on investment than Evotec SE. However, Collegium Pharmaceutical is 1.41 times less risky than Evotec SE. It trades about 0.05 of its potential returns per unit of risk. Evotec SE is currently generating about -0.09 per unit of risk. If you would invest  2,218  in Collegium Pharmaceutical on September 2, 2024 and sell it today you would earn a total of  832.00  from holding Collegium Pharmaceutical or generate 37.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.73%
ValuesDaily Returns

Collegium Pharmaceutical  vs.  Evotec SE

 Performance 
       Timeline  
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Evotec SE 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evotec SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Evotec SE is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Collegium Pharmaceutical and Evotec SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collegium Pharmaceutical and Evotec SE

The main advantage of trading using opposite Collegium Pharmaceutical and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.
The idea behind Collegium Pharmaceutical and Evotec SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments